hVIVO hails Enanta Pharmaceuticals study success
hVIVO hails Enanta Pharmaceuticals’ study success
The US drug developer used the UK company's London facility and its specially designed trial protocol
Original Article: hVIVO hails Enanta Pharmaceuticals’ study success
More From BioPortfolio on "hVIVO hails Enanta Pharmaceuticals’ study success"